Johnson & Johnson’s Q1 2025 report surpassed expectations. The shares have been trading within a sideways range since 2022, and the management’s upbeat forecast for 2025 could prompt a breakout above the upper boundary of this range. Johnson & Johnson (NYSE: JNJ) reported a 2.4% increase in sales in Q1 2025 to 21.9 billion USD, […]
Despite a weak earnings report, investors are actively buying Tesla shares. The 2025 forecast indicates that TSLA stock could climb to 380 USD Tesla’s Q1 2025 report fell short of expectations. The company reported a 39% decline in net income (non-GAAP) to 934 million USD compared to the same period last year. Revenue fell by […]